x
Filter:
Filters applied
- Regular Research Articles
- Journal of Lipid ResearchRemove Journal of Lipid Research filter
Publication Date
Please choose a date range between 2020 and 2022.
Author
- Boeglin, William E3
- Brash, Alan R3
- Artola, Marta2
- Bedi, Shimpi2
- Du, Yuwei2
- Ellis, Shane R2
- He, Yuan2
- Ju, Wen2
- Li, Yue2
- Olivecrona, Gunilla2
- Ory, Daniel S2
- Qiao, Jianlin2
- Radner, Franz PW2
- Xu, Kailin2
- Yao, Ran2
- Zeng, Lingyu2
- Öörni, Katariina2
- Aasa, Ulrika1
- Abe, Akira1
- Abernathy, Breann E1
- Ackerman, Jacobo Miranda1
- Adak, Sangeeta1
- Adam, Safwaan1
- Adams, Charlie H1
- Aerts, Johannes M1
Keyword
- TG30
- triglyceride27
- PC24
- phosphatidylcholine21
- cholesterol20
- inflammation16
- lipids16
- CE15
- lipidomics15
- phosphatidylethanolamine15
- ceramide14
- cholesteryl ester14
- liver14
- PE14
- triacylglycerol14
- lipoproteins13
- atherosclerosis12
- phospholipid12
- PL12
- cardiovascular disease11
- endoplasmic reticulum11
- AA10
- lipid metabolism10
- cDNA9
- complementary DNA9
Regular Research Articles
150 Results
- Research ArticleOpen Access
Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidemia and inflammation
Journal of Lipid ResearchVol. 62100092Published online: June 15, 2021- Sudip Paul
- Adam Alexander T. Smith
- Kevin Culham
- Kevin A. Gunawan
- Jacqueline M. Weir
- Michelle A. Cinel
- and others
Cited in Scopus: 0Plasmalogens are membrane glycerophospholipids with diverse biological functions. Reduced plasmalogen levels have been observed in metabolic diseases; hence, increasing their levels might be beneficial in ameliorating these conditions. Shark liver oil (SLO) is a rich source of alkylglycerols that can be metabolized into plasmalogens. This study was designed to evaluate the impact of SLO supplementation on endogenous plasmalogen levels in individuals with features of metabolic disease. In this randomized, double-blind, placebo-controlled cross-over study, the participants (10 overweight or obese males) received 4-g Alkyrol® (purified SLO) or placebo (methylcellulose) per day for 3 weeks followed by a 3-week washout phase and were then crossed over to 3 weeks of the alternate placebo/Alkyrol® treatment. - Research ArticleOpen Access
Carboxylesterase 1d (Ces1d) does not contribute to cholesteryl ester hydrolysis in the liver
Journal of Lipid ResearchVol. 62100093Published online: June 17, 2021- Jihong Lian
- Jelske N. van der Veen
- Russell Watts
- René L. Jacobs
- Richard Lehner
Cited in Scopus: 0The liver is the central organ regulating cholesterol synthesis, storage, transport, and elimination. Mouse carboxylesterase 1d (Ces1d) and its human ortholog CES1 have been described to possess lipase activity and play roles in hepatic triacylglycerol metabolism and VLDL assembly. It has been proposed that Ces1d/CES1 might also catalyze cholesteryl ester (CE) hydrolysis in the liver and thus be responsible for the hydrolysis of HDL-derived CE; this could contribute to the final step in the reverse cholesterol transport (RCT) pathway, wherein cholesterol is secreted from the liver into bile and feces, either directly or after conversion to water-soluble bile salts. - Research ArticleOpen Access
Lipidomic and transcriptional analysis of the linoleoyl-omega-hydroxyceramide biosynthetic pathway in human psoriatic lesions
Journal of Lipid ResearchVol. 62100094Published online: June 21, 2021- Victoria J. Tyrrell
- Faraz Ali
- William E. Boeglin
- Robert Andrews
- James Burston
- James C. Birchall
- and others
Cited in Scopus: 0A complex assembly of lipids including fatty acids, cholesterol, and ceramides is vital to the integrity of the mammalian epidermal barrier. The formation of this barrier requires oxidation of the substrate fatty acid, linoleic acid (LA), which is initiated by the enzyme 12R-lipoxygenase (LOX). In the epidermis, unoxidized LA is primarily found in long-chain acylceramides termed esterified omega-hydroxy sphingosine (EOS)/phytosphingosine/hydroxysphingosine (collectively EOx). The precise structure and localization of LOX-oxidized EOx in the human epidermis is unknown, as is their regulation in diseases such as psoriasis, one of the most common inflammatory diseases affecting the skin. - Research ArticleOpen Access
PEGylated AdipoRon derivatives improve glucose and lipid metabolism under insulinopenic and high-fat diet conditions
Journal of Lipid ResearchVol. 62100095Published online: June 29, 2021- Toshiharu Onodera
- Ebrahim Ghazvini Zadeh
- Peng Xu
- Ruth Gordillo
- Zheng Guo
- Nolwenn Joffin
- and others
Cited in Scopus: 0The pleiotropic actions of adiponectin in improving cell survival and metabolism have motivated the development of small-molecule therapeutic agents for treating diabetes and lipotoxicity. AdipoRon is a synthetic agonist of the adiponectin receptors, yet is limited by its poor solubility and bioavailability. In this work, we expand on the protective effects of AdipoRon in pancreatic β-cells and examine how structural modifications could affect the activity, pharmacokinetics, and bioavailability of this small molecule. - Research ArticleOpen Access
PCSK9 is not secreted from mature differentiated intestinal cells
Journal of Lipid ResearchVol. 62100096Published online: July 16, 2021- François Moreau
- Aurélie Thédrez
- Damien Garçon
- Audrey Ayer
- Thibaud Sotin
- Wieneke Dijk
- and others
Cited in Scopus: 0Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes lysosomal degradation of the LDL receptor and is a key regulator of cholesterol metabolism. After the liver, the small intestine is the second organ that highly expresses PCSK9. However, the small intestine's ability to secrete PCSK9 remains a matter of debate. While liver-specific PCSK9-deficient mice present no PCSK9 in systemic blood, human intestinal Caco-2 cells can actively secrete PCSK9. This raises the possibility for active intestinal secretion via the portal blood. - Research ArticleOpen Access
Associations of HDL metrics with coronary artery calcium score and density among women traversing menopause
Journal of Lipid ResearchVol. 62100098Published online: July 22, 2021- Samar R. El Khoudary
- Alexis Nasr
- Karen A. Matthews
- Trevor J. Orchard
- Maria M. Brooks
- Jeffrey Billheimer
- and others
Cited in Scopus: 0The cardioprotective association of high-density lipoprotein cholesterol (HDL-C) may vary by menopause stage or estradiol level. We tested whether associations of comprehensive HDL metrics (HDL subclasses, phospholipid and triglyceride content, and HDL cholesterol efflux capacity [HDL-CEC]) with coronary artery calcium (CAC) score and density vary by menopause stage or estradiol level in women transitioning through menopause. Participants (N = 294; mean age [SD]: 51.3 [2.9]) had data on HDL metrics and CAC measures at one or two time points during the menopause transition. - Research ArticleOpen Access
Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
Journal of Lipid ResearchVol. 62100099Published online: July 26, 2021- John T. Melchior
- Scott E. Street
- Tomas Vaisar
- Rachel Hart
- Jay Jerome
- Zsuzsanna Kuklenyik
- and others
Cited in Scopus: 0Human high-density lipoproteins (HDLs) are a complex mixture of structurally related nanoparticles that perform distinct physiological functions. We previously showed that human HDL containing apolipoprotein A-I (APOA1) but not apolipoprotein A-II (APOA2), designated LpA-I, is composed primarily of two discretely sized populations. Here, we isolated these particles directly from human plasma by antibody affinity chromatography, separated them by high-resolution size-exclusion chromatography and performed a deep molecular characterization of each species. - Research ArticleOpen Access
Differential contributions of choline phosphotransferases CPT1 and CEPT1 to the biosynthesis of choline phospholipids
Journal of Lipid ResearchVol. 62100100Published online: July 28, 2021- Yasuhiro Horibata
- Hiroyuki Sugimoto
Cited in Scopus: 0Choline phospholipids (PLs) such as phosphatidylcholine (PC) and 1-alkyl-2-acyl-sn-glycerophosphocholine are important components for cell membranes and also serve as a source of several lipid mediators. These lipids are biosynthesized in mammals in the final step of the CDP-choline pathway by the choline phosphotransferases choline phosphotransferase 1 (CPT1) and choline/ethanolamine phosphotransferase 1 (CEPT1). However, the contributions of these enzymes to the de novo biosynthesis of lipids remain unknown. - Research ArticleOpen Access
Antisense oligonucleotide–mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice
Journal of Lipid ResearchVol. 62100101Published online: August 5, 2021- Thomas A. Bell III
- Mingxia Liu
- Aaron J. Donner
- Richard G. Lee
- Adam E. Mullick
- Rosanne M. Crooke
Cited in Scopus: 0Supported by an abundance of experimental and genetic evidence, angiopoietin-like protein 3 (ANGPTL3) has emerged as a promising therapeutic target for cardiovascular disease. ANGPTL3 is primarily produced by the liver and is a potent modulator of plasma lipids and lipoproteins. Experimental models and subjects with loss-of-function Angptl3 mutations typically present with lower levels of HDL-C than noncarriers. The effect of ANGPTL3 on HDL-C is typically attributed to its function as an inhibitor of the enzyme endothelial lipase. - Research ArticleOpen Access
The forkhead box transcription factor FoxP4 regulates thermogenic programs in adipocytes
Journal of Lipid ResearchVol. 62100102Published online: August 8, 2021- Luce Perie
- Narendra Verma
- Elisabetta Mueller
Cited in Scopus: 0Forkhead box transcription factors have been shown to be involved in various developmental and differentiation processes. In particular, members of the FoxP family have been previously characterized in depth for their participation in the regulation of lung and neuronal cell differentiation and T-cell development and function; however, their role in adipocyte functionality has not yet been investigated. Here, we report for the first time that Forkhead box P4 (FoxP4) is expressed at high levels in subcutaneous fat depots and mature thermogenic adipocytes. - Research ArticleOpen Access
Nonalcoholic fatty liver disease stratification by liver lipidomics
Journal of Lipid ResearchVol. 62100104Published online: August 9, 2021- Olga Vvedenskaya
- Tim Daniel Rose
- Oskar Knittelfelder
- Alessandra Palladini
- Judith Andrea Heidrun Wodke
- Kai Schuhmann
- and others
Cited in Scopus: 17Nonalcoholic fatty liver disease (NAFLD) is a common metabolic dysfunction leading to hepatic steatosis. However, NAFLD's global impact on the liver lipidome is poorly understood. Using high-resolution shotgun mass spectrometry, we quantified the molar abundance of 316 species from 22 major lipid classes in liver biopsies of 365 patients, including nonsteatotic patients with normal or excessive weight, patients diagnosed with NAFL (nonalcoholic fatty liver) or NASH (nonalcoholic steatohepatitis), and patients bearing common mutations of NAFLD-related protein factors. - Research ArticleOpen Access
A novel compound heterozygous leptin receptor mutation causes more severe obesity than in Leprdb/db mice
Journal of Lipid ResearchVol. 62100105Published online: August 10, 2021- Claudia Berger
- Henrike O. Heyne
- Tina Heiland
- Sebastian Dommel
- Corinna Höfling
- Esther Guiu-Jurado
- and others
Cited in Scopus: 0The leptin receptor (Lepr) pathway is important for food intake regulation, energy expenditure, and body weight. Mutations in leptin and the Lepr have been shown to cause early-onset severe obesity in mice and humans. In studies with C57BL/6NCrl mice, we found a mouse with extreme obesity. To identify a putative spontaneous new form of monogenic obesity, we performed backcross studies with this mouse followed by a quantitative trait locus (QTL) analysis and sequencing of the selected chromosomal QTL region. - Research ArticleOpen Access
EPA and DHA containing phospholipids have contrasting effects on membrane structure
Journal of Lipid ResearchVol. 62100106Published online: August 12, 2021- Samuel C.R. Sherratt
- Rebecca A. Juliano
- Christina Copland
- Deepak L. Bhatt
- Peter Libby
- R. Preston Mason
Cited in Scopus: 0Omega-3 FAs EPA and DHA influence membrane fluidity, lipid rafts, and signal transduction. A clinical trial, Reduction of Cardiovascular Events with Icosapent Ethyl—Intervention Trial, demonstrated that high-dose EPA (4 g/d icosapent ethyl) reduced composite cardiovascular events in statin-treated high-risk patients. EPA benefits correlated with on-treatment levels, but similar trials using DHA-containing formulations did not show event reduction. We hypothesized that differences in clinical efficacy of various omega-3 FA preparations could result from differential effects on membrane structure. - Research ArticleOpen Access
Pregnancy is accompanied by larger high density lipoprotein particles and compositionally distinct subspecies
Journal of Lipid ResearchVol. 62100107Published online: August 17, 2021- John T. Melchior
- Debi K. Swertfeger
- Jamie Morris
- Scott E. Street
- Carri R. Warshak
- Jeffrey A. Welge
- and others
Cited in Scopus: 0Pregnancy is accompanied by significant physiological changes, which can impact the health and development of the fetus and mother. Pregnancy-induced changes in plasma lipoproteins are well documented, with modest to no impact observed on the generic measure of high density lipoprotein (HDL) cholesterol. However, the impact of pregnancy on the concentration and composition of HDL subspecies has not been examined in depth. In this prospective study, we collected plasma from 24 nonpregnant and 19 pregnant women in their second trimester. - Research ArticleOpen Access
Distinct biological activities of isomers from several families of branched fatty acid esters of hydroxy fatty acids (FAHFAs)
Journal of Lipid ResearchVol. 62100108Published online: August 18, 2021- Pratik Aryal
- Ismail Syed
- Jennifer Lee
- Rucha Patel
- Andrew T. Nelson
- Dionicio Siegel
- and others
Cited in Scopus: 14Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids with antidiabetic and anti-inflammatory effects. Each FAHFA family consists of esters with different acyl chains and multiple isomers with branch points at different carbons. Some FAHFAs, including palmitic acid hydroxy stearic acids (PAHSAs), improve insulin sensitivity and glucose tolerance in mice by enhancing glucose-stimulated insulin secretion (GSIS), insulin-stimulated glucose transport, and insulin action to suppress hepatic glucose production and reducing adipose tissue inflammation. - Research ArticleOpen Access
Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase
Journal of Lipid ResearchVol. 62100109Published online: August 21, 2021- Annalisa Contursi
- Simone Schiavone
- Melania Dovizio
- Christine Hinz
- Rosa Fullone
- Stefania Tacconelli
- and others
Cited in Scopus: 1Platelets promote tumor metastasis by inducing promalignant phenotypes in cancer cells and directly contributing to cancer-related thrombotic complications. Platelet-derived extracellular vesicles (EVs) can promote epithelial-mesenchymal transition (EMT) in cancer cells, which confers high-grade malignancy. 12S-hydroxyeicosatetraenoic acid (12-HETE) generated by platelet-type 12-lipoxygenase (12-LOX) is considered a key modulator of cancer metastasis through unknown mechanisms. In platelets, 12-HETE can be esterified into plasma membrane phospholipids (PLs), which drive thrombosis. - Research ArticleOpen Access
Fatty acyl availability modulates cardiolipin composition and alters mitochondrial function in HeLa cells
Journal of Lipid ResearchVol. 62100111Published online: August 24, 2021- Gregor Oemer
- Marie-Luise Edenhofer
- Yvonne Wohlfarter
- Katharina Lackner
- Geraldine Leman
- Jakob Koch
- and others
Cited in Scopus: 0The molecular assembly of cells depends not only on the balance between anabolism and catabolism but to a large degree on the building blocks available in the environment. For cultured mammalian cells, this is largely determined by the composition of the applied growth medium. Here, we study the impact of lipids in the medium on mitochondrial membrane architecture and function by combining LC-MS/MS lipidomics and functional tests with lipid supplementation experiments in an otherwise serum-free and lipid-free cell culture model. - Research ArticleOpen Access
Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
Journal of Lipid ResearchVol. 62100112Published online: August 26, 2021- Kelli L. Sylvers-Davie
- Ashley Segura-Roman
- Alicia M. Salvi
- Kylie J. Schache
- Brandon S.J. Davies
Cited in Scopus: 0High plasma triglyceride (TG) levels and low HDL-C levels are risk factors for atherosclerosis and cardiovascular disease. Both plasma TG and HDL-C levels are regulated in part by the circulating inhibitor, angiopoietin-like 3 (ANGPTL3). ANGPTL3 inhibits the phospholipase, endothelial lipase (EL), which hydrolyzes the phospholipids of HDL, thus decreasing plasma HDL levels. ANGPTL3 also inhibits LPL, the lipase primarily responsible for the clearance of TGs from the circulation. Previous studies have shown that ANGPTL3 requires complex formation with the related ANGPTL protein, angiopoietin-like 8 (ANGPTL8), to efficiently inhibit LPL, but the role of ANGPTL8 in EL inhibition is not known. - Research ArticleOpen Access
Omega-3 versus Omega-6 fatty acid availability is controlled by hydrophobic site geometries of phospholipase A2s
Journal of Lipid ResearchVol. 62100113Published online: August 30, 2021- Daiki Hayashi
- Varnavas D. Mouchlis
- Edward A. Dennis
Cited in Scopus: 0Human phospholipase A2s (PLA2) constitute a superfamily of enzymes that hydrolyze the sn-2 acyl-chain of glycerophospholipids, producing lysophospholipids and free fatty acids. Each PLA2 enzyme type contributes to specific biological functions based on its expression, subcellular localization, and substrate specificity. Among the PLA2 superfamily, the cytosolic cPLA2 enzymes, calcium-independent iPLA2 enzymes, and secreted sPLA2 enzymes are implicated in many diseases, but a central issue is the preference for double-bond positions in polyunsaturated fatty acids (PUFAs) occupying the sn-2 position of membrane phospholipids. - Research ArticleOpen Access
HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts
Journal of Lipid ResearchVol. 62100114Published online: September 2, 2021- Nina H. Pipalia
- Syed Z. Saad
- Kanagaraj Subramanian
- Abigail Cross
- Aisha al-Motawa
- Kunal Garg
- and others
Cited in Scopus: 0Niemann-Pick type C1 (NPC1) disease is a lysosomal lipid storage disorder caused by mutations of the NPC1 gene. More than 300 disease-associated mutations are reported in patients, resulting in abnormal accumulation of unesterified cholesterol, glycosphingolipids, and other lipids in late endosomes and lysosomes (LE/Ly) of many cell types. Previously, we showed that treatment of many different NPC1 mutant fibroblasts with histone deacetylase inhibitors resulted in reduction of cholesterol storage, and we found that this was associated with enhanced exit of the NPC1 protein from the endoplasmic reticulum and delivery to LE/Ly. - Research ArticleOpen Access
CXCL5 secreted from macrophages during cold exposure mediates white adipose tissue browning
Journal of Lipid ResearchVol. 62100117Published online: September 16, 2021- Dabin Lee
- Dong Wook Kim
- Sanghyuk Yoon
- A-Reum Nam
- Kang-Hoon Lee
- Ki-Hoan Nam
- and others
Cited in Scopus: 0Adipose tissue affects metabolic-related diseases because it consists of various cell types involved in fat metabolism and adipokine release. CXC ligand 5 (CXCL5) is a member of the CXC chemokine family and is highly expressed by macrophages in white adipose tissue (WAT). In this study, we generated and investigated the function of CXCL5 in knockout (KO) mice using CRISPR/Cas9. The male KO mice did not show significant phenotype differences in normal conditions. However, proteomic analysis revealed that many proteins involved in fatty acid beta-oxidation and mitochondrial localization were enriched in the inguinal WAT (iWAT) of Cxcl5 KO mice. - Research ArticleOpen Access
The maternal blood lipidome is indicative of the pathogenesis of severe preeclampsia
Journal of Lipid ResearchVol. 62100118Published online: September 18, 2021- Bing He
- Yu Liu
- Mano R. Maurya
- Paula Benny
- Cameron Lassiter
- Hui Li
- and others
Cited in Scopus: 0Preeclampsia is a pregnancy-specific syndrome characterized by hypertension and proteinuria after 20 weeks of gestation. However, it is not well understood what lipids are involved in the development of this condition, and even less is known how these lipids mediate its formation. To reveal the relationship between lipids and preeclampsia, we conducted lipidomic profiling of maternal sera of 44 severe preeclamptic and 20 healthy pregnant women from a multiethnic cohort in Hawaii. Correlation network analysis showed that oxidized phospholipids have increased intercorrelations and connections in preeclampsia, whereas other lipids, including triacylglycerols, have reduced network correlations and connections. - Research ArticleOpen Access
Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways
Journal of Lipid ResearchVol. 62100121Published online: September 21, 2021- Viktor Bugajev
- Tomas Paulenda
- Pavol Utekal
- Michal Mrkacek
- Ivana Halova
- Ladislav Kuchar
- and others
Cited in Scopus: 0Leukotrienes (LTs) and sphingolipids are critical lipid mediators participating in numerous cellular signal transduction events and developing various disorders, such as bronchial hyperactivity leading to asthma. Enzymatic reactions initiating production of these lipid mediators involve 5-lipoxygenase (5-LO)-mediated conversion of arachidonic acid to LTs and serine palmitoyltransferase (SPT)-mediated de novo synthesis of sphingolipids. Previous studies have shown that endoplasmic reticulum membrane protein ORM1-like protein 3 (ORMDL3) inhibits the activity of SPT and subsequent sphingolipid synthesis. - Research ArticleOpen Access
Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts
Journal of Lipid ResearchVol. 62100122Published online: September 23, 2021- Gergely Karsai
- Regula Steiner
- Andres Kaech
- Museer A. Lone
- Arnold von Eckardstein
- Thorsten Hornemann
Cited in Scopus: 0Hereditary sensory neuropathy type 1 (HSAN1) is a rare axonopathy, characterized by a progressive loss of sensation (pain, temperature, and vibration), neuropathic pain, and wound healing defects. HSAN1 is caused by several missense mutations in the serine palmitoyltransferase long-chain base subunit 1 and serine palmitoyltransferase long-chain base subunit 2 of the enzyme serine palmitoyltransferase—the key enzyme for the synthesis of sphingolipids. The mutations change the substrate specificity of serine palmitoyltransferase, which then forms an atypical class of 1-deoxy-sphinglipids (1-deoxySLs). - Research ArticleOpen Access
Inhibition of chylomicron assembly leads to dissociation of hepatic steatosis from inflammation and fibrosis
Journal of Lipid ResearchVol. 62100123Published online: September 23, 2021- Yan Xie
- Elizabeth P. Newberry
- Elizabeth M. Brunt
- Samuel J. Ballentine
- Saeed Soleymanjahi
- Elizabeth A. Molitor
- and others
Cited in Scopus: 0Regulating dietary fat absorption may impact progression of nonalcoholic fatty liver disease (NAFLD). Here, we asked if inducible inhibition of chylomicron assembly, as observed in intestine-specific microsomal triglyceride (TG) transfer protein knockout mice (Mttp-IKO), could retard NAFLD progression and/or reverse established fibrosis in two dietary models. Mttp-IKO mice fed a methionine/choline-deficient (MCD) diet exhibited reduced hepatic TGs, inflammation, and fibrosis, associated with reduced oxidative stress and downstream activation of c-Jun N-terminal kinase and nuclear factor kappa B signaling pathways. - Research ArticleOpen Access
ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species
Journal of Lipid ResearchVol. 62100128Published online: September 27, 2021- Monique Budani
- Christiane Auray-Blais
- Clifford Lingwood
Cited in Scopus: 0The cytosolic-oriented glucosylceramide (GlcCer) synthase is enigmatic, requiring nascent GlcCer translocation to the luminal Golgi membrane to access glycosphingolipid (GSL) anabolic glycosyltransferases. The mechanism by which GlcCer is flipped remains unclear. To investigate the role of GlcCer-binding partners in this process, we previously made cleavable, biotinylated, photoreactive GlcCer analogs in which the reactive nitrene was closely apposed to the GlcCer head group, while maintaining a C16-acyl chain. - Research ArticleOpen Access
Red blood cell triglycerides—a unique pool that incorporates plasma-free fatty acids and relates to metabolic health
Journal of Lipid ResearchVol. 62100131Published online: October 3, 2021- Yilin Song
- Michael D. Jensen
Cited in Scopus: 0Most research into red blood cell (RBC) lipids focuses on membrane phospholipids and their relationships to metabolic conditions and diet. Triglycerides (TGs) exist in most cells; the TG-fatty acids serve as readily available fuel for oxidative phosphorylation. Because RBCs lack mitochondria, they would not be expected to store fatty acids in TG. We followed up on a previous in vitro study that found FFA can be incorporated into RBC-TG by testing whether intravenously infused [U-13C]palmitate could be detected in RBC-TG. - Research ArticleOpen Access
Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet
Journal of Lipid ResearchVol. 62100133Published online: October 5, 2021- Michael W. Lopresti
- Wenqi Cui
- Breann E. Abernathy
- Gavin Fredrickson
- Fanta Barrow
- Arnav S. Desai
- and others
Cited in Scopus: 0Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipid droplets in hepatocytes. NAFLD development and progression is associated with an increase in hepatic cholesterol levels and decreased autophagy and lipophagy flux. Previous studies have shown that the expression of lysosomal acid lipase (LAL), encoded by the gene LIPA, which can hydrolyze both triglyceride and cholesteryl esters, is inversely correlated with the severity of NAFLD. In addition, ablation of LAL activity results in profound NAFLD. - Research ArticleOpen Access
Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70−/− mice by reducing fat absorption
Journal of Lipid ResearchVol. 62100134Published online: October 6, 2021- Rumei Li
- Anna Palmiotti
- Hilde D. de Vries
- Milaine V. Hovingh
- Martijn Koehorst
- Niels L. Mulder
- and others
Cited in Scopus: 0Bile acids (BAs) play important roles in lipid homeostasis, and BA signaling pathways serve as therapeutic targets for nonalcoholic fatty liver disease (NAFLD). Recently, we generated cytochrome P450, family 2, subfamily C, polypeptide 70 (Cyp2c70−/−) mice with a human-like BA composition lacking mouse-/rat-specific muricholic acids to accelerate translation from mice to humans. We employed this model to assess the consequences of a human-like BA pool on diet-induced obesity and NAFLD development. - Research ArticleOpen Access
Altered HDL proteome predicts incident CVD in chronic kidney disease patients
Journal of Lipid ResearchVol. 62100135Published online: October 8, 2021- Baohai Shao
- Anna V. Mathew
- Carissa Thornock
- Subramaniam Pennathur
- for the Michigan Kidney Translational Core CPROBE Investigator Group
Cited in Scopus: 0Patients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional lipid risk factors, including low HDL levels, cannot completely explain the increased risk. Altered HDL proteome is linked with both CVD and CKD, but the role of HDL proteins in incident CVD events in patients with CKD is unknown. In this prospective case-control study, we used targeted proteomics to quantify 31 HDL proteins in 92 subjects (46 incident new CVD and 46 one-to-one matched controls) at various stages of CKD. - Research ArticleOpen Access
Vitamin D deficiency promotes accumulation of bioactive lipids and increased endocannabinoid tone in zebrafish
Journal of Lipid ResearchVol. 62100142Published online: October 17, 2021- Megan M. Knuth
- Whitney L. Stutts
- Morgan M. Ritter
- Kenneth P. Garrard
- Seth W. Kullman
Cited in Scopus: 3Vitamin D is well known for its traditional role in bone mineral homeostasis; however, recent evidence suggests that vitamin D also plays a significant role in metabolic control. This study served to investigate putative linkages between vitamin D deficiency (VDD) and metabolic disruption of bioactive lipids by MS imaging. Our approach employed infrared-matrix-assisted laser desorption electrospray ionization MS imaging for lipid metabolite profiling in 6-month-old zebrafish fed either a VDD or a vitamin D-sufficient (VDS) diet. - Research ArticleOpen Access
Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension
Journal of Lipid ResearchVol. 62100145Published online: October 25, 2021- Monika Lakk
- Grace F. Hoffmann
- Aruna Gorusupudi
- Eric Enyong
- Amy Lin
- Paul S. Bernstein
- and others
Cited in Scopus: 0Despite the association of cholesterol with debilitating pressure-related diseases such as glaucoma, heart disease, and diabetes, its role in mechanotransduction is not well understood. We investigated the relationship between mechanical strain, free membrane cholesterol, actin cytoskeleton, and the stretch-activated transient receptor potential vanilloid isoform 4 (TRPV4) channel in human trabecular meshwork (TM) cells. Physiological levels of cyclic stretch resulted in time-dependent decreases in membrane cholesterol/phosphatidylcholine ratio and upregulation of stress fibers. - Research ArticleOpen Access
Amodiaquine promotes testosterone production and de novo synthesis of cholesterol and triglycerides in Leydig cells
Journal of Lipid ResearchVol. 62100152Published online: November 18, 2021- Yujeong Choi
- Eun Goo Lee
- Gibbeum Lee
- Mi Gyeong Jeong
- Hyo Kyeong Kim
- Ji-Hyun Oh
- and others
Cited in Scopus: 0Testosterone is a hormone essential for male reproductive function. It is produced primarily by Leydig cells in the testicle through activation of steroidogenic acute regulatory protein and a series of steroidogenic enzymes, including a cytochrome P450 side-chain cleavage enzyme (cytochome P450 family 11 subfamily A member 1), 17α-hydroxylase (cytochrome P450 family 17 subfamily A member 1), and 3β-hydroxysteroid dehydrogenase. These steroidogenic enzymes are mainly regulated at the transcriptional level, and their expression is increased by the nuclear receptor 4A1. - Research ArticleOpen Access
Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis
Journal of Lipid ResearchVol. 62100019Published online: January 5, 2021- Montgomery Blencowe
- In Sook Ahn
- Zara Saleem
- Helen Luk
- Ingrid Cely
- Ville-Petteri Mäkinen
- and others
Cited in Scopus: 0Genome-wide association studies (GWASs) have implicated ∼380 genetic loci for plasma lipid regulation. However, these loci only explain 17–27% of the trait variance, and a comprehensive understanding of the molecular mechanisms has not been achieved. In this study, we utilized an integrative genomics approach leveraging diverse genomic data from human populations to investigate whether genetic variants associated with various plasma lipid traits, namely, total cholesterol, high and low density lipoprotein cholesterol (HDL and LDL), and triglycerides, from GWASs were concentrated on specific parts of tissue-specific gene regulatory networks. - Research ArticleOpen Access
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
Journal of Lipid ResearchVol. 62100031Published online: February 5, 2021- Mingfeng Xia
- Preethi Chandrasekaran
- Shunxing Rong
- Xiaorong Fu
- Matthew A. Mitsche
Cited in Scopus: 0Genetic variants that increase the risk of fatty liver disease and cirrhosis have recently been identified in the proximity of membrane-bound O-acyltransferase domain-containing 7 (MBOAT7). To elucidate the link between these variants and fatty liver disease, we characterized Mboat7 liver-specific KO mice (Mboat7 LSKO). Chow-fed Mboat7 LSKO mice developed fatty livers and associated liver injury. Lipidomic analysis of liver using MS revealed a pronounced reduction in 20-carbon PUFA content in phosphatidylinositols (PIs) but not in other phospholipids. - Research ArticleOpen Access
Dietary sphinganine is selectively assimilated by members of the mammalian gut microbiome
Journal of Lipid ResearchVol. 62100034Published online: February 5, 2021- Min-Ting Lee
- Henry H. Le
- Elizabeth L. Johnson
Cited in Scopus: 0Functions of the gut microbiome have a growing number of implications for host metabolic health, with diet being one of the most significant influences on microbiome composition. Compelling links between diet and the gut microbiome suggest key roles for various macronutrients, including lipids, yet how individual classes of dietary lipids interact with the microbiome remains largely unknown. Sphingolipids are bioactive components of most foods and are also produced by prominent gut microbes. This makes sphingolipids intriguing candidates for shaping diet-microbiome interactions. - Research ArticleOpen Access
High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity
Journal of Lipid ResearchVol. 62100043Published online: February 5, 2021- Jan Hoong Ho
- Kwok Leung Ong
- Luisa F. Cuesta Torres
- Yifen Liu
- Safwaan Adam
- Zohaib Iqbal
- and others
Cited in Scopus: 0Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed weight-loss procedures, but how severe obesity and RYGB affect circulating HDL-associated microRNAs (miRNAs) remains unclear. Here, we aim to investigate how HDL-associated miRNAs are regulated in severe obesity and how weight loss after RYGB surgery affects HDL-miRNAs. Plasma HDLs were isolated from patients with severe obesity (n = 53) before and 6 and 12 months after RYGB by immunoprecipitation using goat anti-human apoA-I microbeads. - Research ArticleOpen Access
Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging
Journal of Lipid ResearchVol. 62100020Published online: January 5, 2021- Astrid M. Moerman
- Mirjam Visscher
- Nuria Slijkhuis
- Kim Van Gaalen
- Bram Heijs
- Theo Klein
- and others
Cited in Scopus: 0Carotid atherosclerosis is a risk factor for ischemic stroke, one of the main causes of mortality and disability worldwide. The disease is characterized by plaques, heterogeneous deposits of lipids, and necrotic debris in the vascular wall, which grow gradually and may remain asymptomatic for decades. However, at some point a plaque can evolve to a high-risk plaque phenotype, which may trigger a cerebrovascular event. Lipids play a key role in the development and progression of atherosclerosis, but the nature of their involvement is not fully understood. - Research ArticleOpen Access
Human glucocerebrosidase mediates formation of xylosyl-cholesterol by β-xylosidase and transxylosidase reactions
Journal of Lipid ResearchVol. 62100018Published online: January 5, 2021- Daphne E. Boer
- Mina Mirzaian
- Maria J. Ferraz
- Kimberley C. Zwiers
- Merel V. Baks
- Marc D. Hazeu
- and others
Cited in Scopus: 0Deficiency of glucocerebrosidase (GBA), a lysosomal β-glucosidase, causes Gaucher disease. The enzyme hydrolyzes β-glucosidic substrates and transglucosylates cholesterol to cholesterol-β-glucoside. Here we show that recombinant human GBA also cleaves β-xylosides and transxylosylates cholesterol. The xylosyl-cholesterol formed acts as an acceptor for the subsequent formation of di-xylosyl-cholesterol. Common mutant forms of GBA from patients with Gaucher disease with reduced β-glucosidase activity were similarly impaired in β-xylosidase, transglucosidase, and transxylosidase activities, except for a slightly reduced xylosidase/glucosidase activity ratio of N370S GBA and a slightly reduced transglucosylation/glucosidase activity ratio of D409H GBA. - Research ArticleOpen Access
Palmitoylation of acetylated tubulin and association with ceramide-rich platforms is critical for ciliogenesis
Journal of Lipid ResearchVol. 62100021Published online: January 7, 2021- Priyanka Tripathi
- Zhihui Zhu
- Haiyan Qin
- Ahmed Elsherbini
- Simone M. Crivelli
- Emily Roush
- and others
Cited in Scopus: 0Microtubules are polymers composed of αβ-tubulin subunits that provide structure to cells and play a crucial role in in the development and function of neuronal processes and cilia, microtubule-driven extensions of the plasma membrane that have sensory (primary cilia) or motor (motile cilia) functions. To stabilize microtubules in neuronal processes and cilia, α tubulin is modified by the posttranslational addition of an acetyl group, or acetylation. We discovered that acetylated tubulin in microtubules interacts with the membrane sphingolipid, ceramide. - Research ArticleOpen Access
Perilipin 5 S155 phosphorylation by PKA is required for the control of hepatic lipid metabolism and glycemic control
Journal of Lipid ResearchVol. 62100016Published online: December 21, 2020- Stacey N. Keenan
- William De Nardo
- Jieqiong Lou
- Ralf B. Schittenhelm
- Magdalene K. Montgomery
- James G. Granneman
- and others
Cited in Scopus: 0Perilipin 5 (PLIN5) is a lipid-droplet-associated protein that coordinates intracellular lipolysis in highly oxidative tissues and is thought to regulate lipid metabolism in response to phosphorylation by protein kinase A (PKA). We sought to identify PKA phosphorylation sites in PLIN5 and assess their functional relevance in cultured cells and the livers of mice. We detected phosphorylation on S155 and identified S155 as a functionally important site for lipid metabolism. Expression of phosphorylation-defective PLIN5 S155A in Plin5 null cells resulted in decreased rates of lipolysis and triglyceride-derived fatty acid oxidation. - Research ArticleOpen Access
Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet
Journal of Lipid ResearchVol. 62100013Published online: December 17, 2020- Thibaut Bourgeois
- Antoine Jalil
- Charles Thomas
- Charlène Magnani
- Naig Le Guern
- Thomas Gautier
- and others
Cited in Scopus: 0Recent studies have highlighted an important role for lysophosphatidylcholine acyltransferase 3 (LPCAT3) in controlling the PUFA composition of cell membranes in the liver and intestine. In these organs, LPCAT3 critically supports cell-membrane-associated processes such as lipid absorption or lipoprotein secretion. However, the role of LPCAT3 in macrophages remains controversial. Here, we investigated LPCAT3's role in macrophages both in vitro and in vivo in mice with atherosclerosis and obesity. - Research ArticleOpen Access
Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease
Journal of Lipid ResearchVol. 62100014Published online: December 17, 2020- Yueming Hu
- Cristiana Meuret
- Ashley Martinez
- Hussein N. Yassine
- Dobrin Nedelkov
Cited in Scopus: 0Apolipoproteins C-I, C-II, and C-III interact with ApoE to regulate lipoprotein metabolism and contribute to Alzheimer's disease pathophysiology. In plasma, apoC-I and C-II exist as truncated isoforms, while apoC-III exhibits multiple glycoforms. This study aimed to 1) delineate apoC-I, C-II, and C-III isoform profiles in cerebrospinal fluid (CSF) and plasma in a cohort of nondemented older individuals (n = 61), and 2) examine the effect of APOE4 on these isoforms and their correlation with CSF Aβ42, a surrogate of brain amyloid accumulation. - Research ArticleOpen Access
Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice
Journal of Lipid ResearchVol. 62100011Published online: December 15, 2020- Aloïs Dusuel
- Valérie Deckert
- Jean-Paul Pais de Barros
- Kevin van Dongen
- Hélène Choubley
- Émilie Charron
- and others
Cited in Scopus: 0Bacterial lipopolysaccharides (LPSs or endotoxins) can bind most proteins of the lipid transfer/LPS-binding protein (LT/LBP) family in host organisms. The LPS-bound LT/LBP proteins then trigger either an LPS-induced proinflammatory cascade or LPS binding to lipoproteins that are involved in endotoxin inactivation and detoxification. Cholesteryl ester transfer protein (CETP) is an LT/LBP member, but its impact on LPS metabolism and sepsis outcome is unclear. Here, we performed fluorescent LPS transfer assays to assess the ability of CETP to bind and transfer LPS. - Research ArticleOpen Access
Mutation in the distal NPxY motif of LRP1 alleviates dietary cholesterol-induced dyslipidemia and tissue inflammation
Journal of Lipid ResearchVol. 62100012Published online: December 15, 2020- Anja Jaeschke
- April Haller
- James G. Cash
- Christopher Nam
- Emily Igel
- Anton J.M. Roebroek
- and others
Cited in Scopus: 0The impairment of LDL receptor-related protein-1 (LRP1) in numerous cell types is associated with obesity, diabetes, and fatty liver disease. Here, we compared the metabolic phenotype of C57BL/6J wild-type and LRP1 knock-in mice carrying an inactivating mutation in the distal NPxY motif after feeding a low-fat diet or high-fat (HF) diet with cholesterol supplementation (HFHC) or HF diet without cholesterol supplementation. In response to HF feeding, both groups developed hyperglycemia, hyperinsulinemia, hyperlipidemia, increased adiposity, and adipose tissue inflammation and liver steatosis. - Research ArticleOpen Access
rHDL modeling and the anchoring mechanism of LCAT activation
Journal of Lipid ResearchVol. 62100006Published online: December 9, 2020- Tommaso Laurenzi
- Chiara Parravicini
- Luca Palazzolo
- Uliano Guerrini
- Elisabetta Gianazza
- Laura Calabresi
- and others
Cited in Scopus: 0Lecithin:cholesterol-acyl transferase (LCAT) plays a major role in cholesterol metabolism as it is the only extracellular enzyme able to esterify cholesterol. LCAT activity is required for lipoprotein remodeling and, most specifically, for the growth and maturation of HDLs. In fact, genetic alterations affecting LCAT functionality may cause a severe reduction in plasma levels of HDL-cholesterol with important clinical consequences. Although several hypotheses were formulated, the exact molecular recognition mechanism between LCAT and HDLs is still unknown. - Research ArticleOpen Access
Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
Journal of Lipid ResearchVol. 62100004Published online: November 23, 2020- Oktawia Nilsson
- Mikaela Lindvall
- Laura Obici
- Simon Ekström
- Jens O. Lagerstedt
- Rita Del Giudice
Cited in Scopus: 0Apolipoprotein A-I (ApoA-I) of high density lipoproteins (HDLs) is essential for the transportation of cholesterol between peripheral tissues and the liver. However, specific mutations in ApoA-I of HDLs are responsible for a late-onset systemic amyloidosis, the pathological accumulation of protein fibrils in tissues and organs. Carriers of these mutations do not exhibit increased cardiovascular disease risk despite displaying reduced levels of ApoA-I/HDL cholesterol. To explain this paradox, we show that the HDL particle profiles of patients carrying either L75P or L174S ApoA-I amyloidogenic variants show a higher relative abundance of the 8.4-nm versus 9.6-nm particles and that serum from patients, as well as reconstituted 8.4- and 9.6-nm HDL particles (rHDL), possess increased capacity to catalyze cholesterol efflux from macrophages. - Research ArticleOpen Access
Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9
Journal of Lipid ResearchVol. 62100003Published online: November 22, 2020- Carlota Oleaga
- Joshua Hay
- Emma Gurcan
- Larry L. David
- Paul A. Mueller
- Hagai Tavori
- and others
Cited in Scopus: 0Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates cholesterol metabolism by inducing the degradation of hepatic low density lipoprotein receptors (LDLRs). Plasma PCSK9 has 2 main molecular forms: a 62 kDa mature form (PCSK9_62) and a 55 kDa, furin-cleaved form (PCSK9_55). PCSK9_55 is considered less active than PCSK9_62 in degrading LDLRs. We aimed to identify the site of PCSK9_55 formation (intracellular vs. extracellular) and to further characterize the LDLR-degradative function of PCSK9_55 relative to PCSK9_62. - Research ArticleOpen Access
Generation and validation of a conditional knockout mouse model for the study of the Smith-Lemli-Opitz syndrome
Journal of Lipid ResearchVol. 62100002Published online: November 22, 2020- Babunageswararao Kanuri
- Vincent Fong
- Sithara Raju Ponny
- Keri A. Tallman
- Sriganesh Ramachandra Rao
- Ned Porter
- and others
Cited in Scopus: 0Smith-Lemli-Opitz Syndrome (SLOS) is a developmental disorder (OMIM # 270400 ) caused by autosomal recessive mutations in the Dhcr7 gene, which encodes the enzyme 3β-hydroxysterol-Δ7 reductase. SLOS patients present clinically with dysmorphology and neurological, behavioral, and cognitive defects, with characteristically elevated levels of 7-dehydrocholesterol (7-DHC) in all bodily tissues and fluids. Previous mouse models of SLOS have been hampered by postnatal lethality when Dhcr7 is knocked out globally, while a hypomorphic mouse model showed improvement in the biochemical phenotype with aging and did not manifest most other characteristic features of SLOS. - Research ArticleOpen Access
Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects
Journal of Lipid ResearchVol. 62100001Published online: November 20, 2020- Akemi Kakino
- Yoshiko Fujita
- Liang-Yin Ke
- Hua-Chen Chan
- Ming-Hsien Tsai
- Chia-Yen Dai
- and others
Cited in Scopus: 0Adiponectin, an adipocyte-derived protein, has antiatherogenic and antidiabetic effects, but how it confers the atherogenic effects is not well known. To study the antiatherogenic mechanisms of adiponectin, we examined whether it interacts with atherogenic low density lipoprotein (LDL) to attenuate LDL's atherogenicity. L5, the most electronegative subfraction of LDL, induces atherogenic responses similarly to copper-oxidized LDL (oxLDL). Unlike the native LDL endocytosed via the LDL receptor, L5 and oxLDL are internalized by cells via the lectin-like oxidized LDL receptor-1 (LOX-1).